Medicinal Product Register of Latvia

...	...	...	Active substance	Medicinal product name	Pharmaceutical form	Strength	ATC code	Max. price range (€ incl. VAT)	Additional information regarding the use for persons aged 75+
Is available (according to the information provided by wholesalers)	Rx Prescription (Pr.)		Ondansetronum	Emetron 2 mg/ml solution for injection mark for comparison compare medicines	Solution for injection	2 mg/ml	Is available (according to the information provided by wholesalers) Rx Prescription (Pr.)	A04AA01 — ANTIEMETICS AND ANTINAUSEANTS	€ 17.90	skatīt informāciju par zālēm un iepakojumiem
Is available (according to the information provided by wholesalers)	Rx Prescription (Pr.)	KZSR Reimbursed medicines reference product	Ondansetronum	Emetron 8 mg film-coated tablets mark for comparison compare medicines	Film-coated tablet	8 mg	Is available (according to the information provided by wholesalers) Rx Prescription (Pr.) KZSR Reimbursed medicines reference product	A04AA01 — ANTIEMETICS AND ANTINAUSEANTS	€ 24.16	skatīt informāciju par zālēm un iepakojumiem
Is available (according to the information provided by wholesalers)	Rx Prescription (Pr.)		Ondansetronum	Ondansetron Accord 2 mg/ml solution for injection or infusion mark for comparison compare medicines	Solution for injection/infusion	2 mg/ml	Is available (according to the information provided by wholesalers) Rx Prescription (Pr.)	A04AA01 — ANTIEMETICS AND ANTINAUSEANTS	€ 19.08	skatīt informāciju par zālēm un iepakojumiem
Is available (according to the information provided by wholesalers)	Rx Prescription (Pr.)		Ondansetronum	Ondansetron Baxter 2 mg/ml solution for injection mark for comparison compare medicines	Solution for injection	2 mg/ml	Is available (according to the information provided by wholesalers) Rx Prescription (Pr.)	A04AA01 — ANTIEMETICS AND ANTINAUSEANTS	€ 21.43	skatīt informāciju par zālēm un iepakojumiem
Not available (according to the information provided by wholesalers)	Rx Prescription (Pr.)		Ondansetronum	Ondansetron Kabi 0.08 mg/ml solution for infusion mark for comparison compare medicines	Solution for infusion	0.08 mg/ml	Not available (according to the information provided by wholesalers) Rx Prescription (Pr.)	A04AA01 — ANTIEMETICS AND ANTINAUSEANTS		skatīt informāciju par zālēm un iepakojumiem
Not available (according to the information provided by wholesalers)	Rx Prescription (Pr.)		Ondansetronum	Ondansetron Kabi 0.16 mg/ml solution for infusion mark for comparison compare medicines	Solution for infusion	0.16 mg/ml	Not available (according to the information provided by wholesalers) Rx Prescription (Pr.)	A04AA01 — ANTIEMETICS AND ANTINAUSEANTS		skatīt informāciju par zālēm un iepakojumiem
Is available (according to the information provided by wholesalers)	Rx Prescription (Pr.)		Ondansetronum	Ondansetron Kalceks 2 mg/ml solution for injection/infusion mark for comparison compare medicines	Solution for injection/infusion	2 mg/ml	Is available (according to the information provided by wholesalers) Rx Prescription (Pr.)	A04AA01 — ANTIEMETICS AND ANTINAUSEANTS	€ 12.90–39.27	skatīt informāciju par zālēm un iepakojumiem

* Indication about medicine on the List of state reimbursed medicines is just informative. Source of the information is the National Health Service. For details please visit the NHS website.

Download search results (7 medicines) – ZIP archive containing the list in CSV, JSON and XML format. View list's field descriptions.

Icon explanation

– Medicine is available
– Medicine is not available
– Distribution permitted for a limited time span
– Without a prescription
– Prescription medicine

– Medicine is listed on the Latvian National Health Service (NHS) list of state reimbursed medicines. (source of the information – the NHS)
– Reference medicine on the NHS List of state reimbursed medicines
– Lowest cost medicine within its therapeutic effectiveness class in cases where no reference medicine is available
- – Next lowest cost medicine after or (in ascending order)

Class A A (green): Suitable for the older persons. The medicinal substance can be used as in younger patients. Changes due to aging do not affect the dose or frequency of administration, and the adverse reaction profile is not different from that of younger patients.

Class B B (grey): There is little research evidence, practical experience or efficacy in older persons.

Class C C (yellow): Suitable for older persons, with specific cautions. The medicinal substance can be used by older persons, but the dose might either have to be reduced, or the frequency of administration decreased due to mild or moderate renal insufficiency or a significant risk of interactions or adverse reactions.

Class D D (red): Avoid use in older persons. Use is possible only in exceptional cases or on a one-off basis. Changes due to aging predispose older persons to adverse or dangerous reactions to the drug. The risk of adverse reactions typically exceeds the benefits.

Meds75+ data source is Finnish Medicines Agency Fimea (licensed under CC BY 4.0).
Data updated on Apr 18, 2024.